Trachok_Mat

Mat Trachok

ShareShare
  • Share This Page
  • FacebookFacebook
  • LinkedinLinkedIn
  • X (Formerly Twitter)X (Formerly Twitter)
  • PinterestPinterest
  • EmailEmail
Download IconDownload
Print IconPrint

Mat Trachok's practice focuses on advising clients on technology-centered transactions. Mr. Trachok's clients are primarily in the biotechnology, pharmaceutical and medical device industries, and span the range from established to emerging companies. Mr. Trachok advises clients on developing term sheets and negotiating and drafting complex commercial and intellectual property transactions, including licensing, research collaboration, co-development and co-commercialization agreements.

From 2012 to 2015, Mr. Trachok litigated intellectual property and breach of contract disputes, at the state and federal trial and appellate levels, involving a broad range of technologies, including pharmaceuticals, medical devices, optical networks, near field communication, network interfaces and crop planters. Mr. Trachok's litigation practice encompassed all stages of litigation—from pre- suit investigations through discovery, summary judgment, trial, settlement, alternative dispute resolution and appeal. His appellate experience included the United States Court of Appeals for the Federal Circuit, the Massachusetts Supreme Judicial Court and the Supreme Court of the State of Vermont.

Insights & News

Credentials

  • Education

    • Harvard Business School Online

      Credential of Readiness (CORe), Business Analytics, Financial Accounting, Economics for Managers, with High Honors, 2016
    • JD, Harvard Law School, 2012

      cum laude Co-Editor-in-Chief, National Security Journal
    • BA, International Studies and English, Yale University, 2009

      cum laude
  • Admissions

    • California

    • Massachusetts

    • Nevada

Credentials

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.